CERo Therapeutics Holdings Overview

CERo Therapeutics Holdings EBIT

EBIT (Earnings Before Interest and Taxes) analysis for CERO.

Quarterly EBIT

-$4.85M

↑ 13.14% YoY

As of Mar 31, 2026

Annual EBIT (TTM)

-$18.20M

↓ 5.4% YoY

Trailing 12 months ending Mar 31, 2026

Average EBIT (Comparison Companies)

EBIT History

EBIT Comparison

Annual EBIT Growth Rate (%)

Annual EBIT Growth (Absolute)

Jump to metric

Total Revenue Cost of Revenue Gross Profit Research & Development Selling, General & Admin Operating Income Other Income Expense Net EBIT Income Tax Net Income Profit Margin